medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2017, Number 2

<< Back Next >>

Acta Med 2017; 15 (2)

Diagnosis and treatment of malignant skin tumors

Telich TJE, Monter PA, Baldín AV, Apellaniz CA

Language: Spanish
References: 38
Page: 154-160
PDF size: 349.97 Kb.


ABSTRACT

Skin cancer has become a public health problem due to its high incidence and the considerable percentage that it occupies within the main malignant neoplasias. There are several risk factors to develop this pathology, and it was observed that exposure to UV rays is among the most important. For its study, it is divided into two types: melanoma and non-melanoma skin cancer, which in turn is classified into basal cell and squamous cell carcinoma. Most cases are preventable and respond well to treatment when they are diagnosed promptly; it is, therefore, to be considered a relevant topic within the medical practice.


REFERENCES

  1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012; 166 (5): 1069-1080.

  2. Mohan SV, Chang AL. Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep. 2014; 3: 40-45.

  3. SINAIS/SINAVE/DGE/SALUD/Perfil epidemiológico de los tumores malignos en México. México: 2011; 45.

  4. Gandhi SA, Kampp J. Skin cancer epidemiology, detection and management. Med Clin North Am. 2015; 99 (6): 1323-1335.

  5. Reinstadler DR, Sinha UK. Uncommon cutaneous neoplasms of the head and neck. Facial Plast Surg Clin North Am. 2012; 20 (4): 483- 491.

  6. Xiang F, Lucas R, Hales S, Neale R. Incidence of non-melanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012 empirical relationships. JAMA Dermatol. 2014; 150 (10): 1063-1071.

  7. Ouyang YH. Skin cancer of the head and neck. Semin Plast Surg. 2010; 24 (2): 117-126.

  8. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010; 375 (9715): 673-685.

  9. Gordon R. Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs. 2013; 29 (3): 160-169.

  10. Wu PA. Epidemiology and clinical features of basal cell carcinoma. UpToDate. 2014.

  11. Firnhaber JM. Diagnosis and treatment of basal cell and squemous cell carcinoma. Am Fam Physician. 2012; 86 (2): 161-168.

  12. Ibrahim O, Gastman B, Zhang A. Advances in diagnosis and treatment of nonmelanoma skin cancer. Ann Plast Surg. 2014; 73 (5): 615-619.

  13. Ermertcan AT, Hellings PW, Cingi C. Nonmelanoma skin cancer of the head and neck: nonsurgical treatment. Facial Plast Surg Clin North Am. 2012; 20 (4): 445-454.

  14. Akcam TM, Gubisch W, Unlu H. Nonmelanoma skin cancer of the head and neck: surgical treatment. Facial Plast Surg Clin North Am. 2012; 20 (4): 455-471.

  15. NCCN Clinical Practice Guidelines in Oncology. Basal cell skin cancer, Version 2.2016. Disponible en: https://www.nccn.org/professionals/ physician_gls/f_guidelines.asp

  16. Metterle L, Nelson C, Patel N. Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review. J Am Acad Dermatol. 2016; 74 (3): 552-557.

  17. Bahner JD, Bordeaux JS. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, iquimod, diclofenac, or what? Facts and controversies. Clin Dermatol. 2013; 31 (6): 792-798.

  18. Rong Y, Zuo L, Shang L, Bazan JG. Radiotherapy treatment for nonmelanoma skin cancer. Expert Rev Anticancer Ther. 2015; 15 (7): 765-776.

  19. Song F, Qureshi AA, Giovannucci EL, Fuchs CS, Chen WY, Stampfer MJ et al. Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study. PLoS Med. 2013; 10 (4): e1001433.

  20. Veierød MB, Couto E, Lund E, Adami HO, Weiderpass E. Host characteristics, sun exposure, indoor tanning and risk of squamous cell carcinoma of the skin. Int J Cancer. 2014; 135 (2): 413-422.

  21. Leonardi-Bee J, Ellison T, Bath-Hextall F. Smoking and the risk of nonmelanoma skin cancer: systematic review and meta-analysis. Arch Dermatol. 2012; 148 (8): 939-946.

  22. Prieto-Granada C, Rodriguez-Waitkus P. Cutaneous squamous cell carcinoma and related entities: Epidemiology, clinical and histological features, and basic science overview. Curr Probl Cancer. 2015; 39 (4): 206-215.

  23. Martorell-Calatayud A, Sanmartín-Jiménez O, Cruz-Mojarrieta J, Guillén-Barona C. Cutaneous squamous cell carcinoma: defining the high-risk variant. Actas Dermosifiliogr. 2013; 104 (5): 367-379.

  24. Kallini J, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends. Int J Dermatol. 2015; 54 (2): 130-140.

  25. Divine J, Stefaniwksy L, Reddy R, Padilla P, Hagele T, Patel NS et al. A comprehensive guide to the surgical management of nonmelanoma skin cancer. Curr Probl Cancer. 2015; 39 (4): 216-225.

  26. Metterle L, Russell JS, Patel NS. An overview of the medical management of nonmelanoma skin cancer. Curr Probl Cancer. 2015; 39 (4): 226-226.

  27. NCCN Clinical Practice Guidelines in Oncology. Squamous cell skin cancer, Version 1.2016. Disponible en: https://www.nccn.org/ professionals/physician_gls/f_guidelines.asp

  28. Lansbury L, Bath-Hextall F, Perkins W, Stanton W, Leonardi-Bee J. Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies. BMJ. 2013; 347: f6153.

  29. Kyrgidis A, Tzellos TG, Kechagias N, Patrikidou A, Xirou P, Kitikidou K et al. Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival. Eur J Cancer. 2010; 46 (9): 1563-1572.

  30. Broughman ND, Tan ST. The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma —Implications on the T-classification system. J Surg Oncol. 2014; 110 (7): 876-882.

  31. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64 (1): 9-29.

  32. Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. Lancet. 2014; 383 (9919): 816-827.

  33. Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma. Cancer Prev Res (Phila). 2010; 3 (2): 233-245.

  34. Dickson PV, Gershenwald JE. Staging and prognosis of cutaneous melanoma. Surg Oncol Clin N Am. 2011; 20 (1): 1-17.

  35. Ott PA, Berman RS. Surgical approach to primary cutaneous melanoma. Surg Oncol Clin N Am. 2011; 20 (1): 39-56.

  36. NCCN Clinical Practice Guidelines in Oncology. Melanoma, Version 3.2016. Disponible en: https://www.nccn.org/professionals/ physician_gls/f_guidelines.asp

  37. Farma JM, Kulkarno N, Hsu C. Surgical management of primary and recurrent melanoma. Surg Oncol Clin N Am. 2015; 24 (2): 239-247.

  38. Johnson TM. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2013; 69 (6): 1049-1050.




2020     |     www.medigraphic.com